Report Detail
Global AD Cerebrospinal Fluid (CSF) Assay Kit Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4731160 |
- 13 August, 2026 |
- Global |
- 80 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global AD Cerebrospinal Fluid (CSF) Assay Kit market size was valued at US$ 88.49 million in 2025 and is forecast to a readjusted size of US$ 157 million by 2032 with a CAGR of 8.6% during review period.
Alzheimer's Disease (AD) Cerebrospinal Fluid (CSF) Assay Kit is a laboratory tool used to measure specific proteins in a patient's spinal fluid. These proteins serve as biomarkers for Alzheimer's pathology and aid in diagnosing the disease, even in early or pre-clinical stages.
In 2025, global production of AD Cerebrospinal Fluid (CSF) Assay Kit reached 520 k units, with an average selling price of USD 165 per unit and total production capacity of approximately 650 k units. The industry’s gross margin is approximately 50%–65%. Direct materials account for about 50% of the cost structure, manufacturing overhead accounts for about 42%, and labor costs account for about 8%. In the industry chain, upstream inputs include β-amyloid and Tau-related antibodies/antigens, calibrators and controls, magnetic beads, chemiluminescent or enzyme-linked reaction substrates, etc.; downstream customers include hospitals, third-party medical testing laboratories, pharmaceutical clinical trials/CROs, neurodegenerative disease research institutions, etc.
The global prevalence of Alzheimer’s disease continues to rise, with over 50 million people living with dementia worldwide according to the National Institute on Aging. This growing patient population and the increasing demand for early and accurate diagnosis form the fundamental driver for the AD cerebrospinal fluid (CSF) assay kit market.
CSF biomarker testing, measuring core markers such as Aβ42, pTau181, and tTau, is recognized as the diagnostic gold standard, demonstrating up to 90% concordance with amyloid PET imaging and detecting pathological changes 15 to 20 years before symptom onset. In 2025, China’s NMPA approved the first AD CSF assay kit for clinical use in the country, marking a significant milestone in expanding clinical accessibility. Concurrently, international diagnostic guidelines are shifting toward biomarker-driven frameworks, reinforcing the central role of CSF testing.
Market dynamics are shaped by multiple factors. Global population aging increases disease burden, while the WHO has included dementia in its political declaration on noncommunicable diseases and extended the Global Action Plan on Dementia. However, CSF testing faces constraints including the procedural requirements of lumbar puncture and limited accessibility in resource-constrained settings. Blood-based biomarkers are advancing rapidly but still require confirmation through CSF testing or PET imaging. Overall, the AD CSF assay kit market is at a pivotal stage of diagnostic paradigm transition.
This report is a detailed and comprehensive analysis for global AD Cerebrospinal Fluid (CSF) Assay Kit market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AD Cerebrospinal Fluid (CSF) Assay Kit market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global AD Cerebrospinal Fluid (CSF) Assay Kit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global AD Cerebrospinal Fluid (CSF) Assay Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global AD Cerebrospinal Fluid (CSF) Assay Kit market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AD Cerebrospinal Fluid (CSF) Assay Kit
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AD Cerebrospinal Fluid (CSF) Assay Kit market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Fujirebio, Euroimmun (Revvity), IBL International, Quanterix, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
AD Cerebrospinal Fluid (CSF) Assay Kit market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chemiluminescence
ELISA
Market segment by Biomarker Type
Amyloid-β Biomarkers
p-Tau Biomarkers
t-Tau Biomarkers
Others
Market segment by Application
Medical Diagnosis
Scientific Research
Major players covered
Roche
Fujirebio
Euroimmun (Revvity)
IBL International
Quanterix
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe AD Cerebrospinal Fluid (CSF) Assay Kit product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of AD Cerebrospinal Fluid (CSF) Assay Kit, with price, sales quantity, revenue, and global market share of AD Cerebrospinal Fluid (CSF) Assay Kit from 2021 to 2026.
Chapter 3, the AD Cerebrospinal Fluid (CSF) Assay Kit competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the AD Cerebrospinal Fluid (CSF) Assay Kit breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and AD Cerebrospinal Fluid (CSF) Assay Kit market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of AD Cerebrospinal Fluid (CSF) Assay Kit.
Chapter 14 and 15, to describe AD Cerebrospinal Fluid (CSF) Assay Kit sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global AD Cerebrospinal Fluid (CSF) Assay Kit Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Chemiluminescence
- 1.3.3 ELISA
- 1.4 Market Analysis by Biomarker Type
- 1.4.1 Overview: Global AD Cerebrospinal Fluid (CSF) Assay Kit Consumption Value by Biomarker Type: 2021 Versus 2025 Versus 2032
- 1.4.2 Amyloid-β Biomarkers
- 1.4.3 p-Tau Biomarkers
- 1.4.4 t-Tau Biomarkers
- 1.4.5 Others
- 1.5 Market Analysis by Application
- 1.5.1 Overview: Global AD Cerebrospinal Fluid (CSF) Assay Kit Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.5.2 Medical Diagnosis
- 1.5.3 Scientific Research
- 1.6 Global AD Cerebrospinal Fluid (CSF) Assay Kit Market Size & Forecast
- 1.6.1 Global AD Cerebrospinal Fluid (CSF) Assay Kit Consumption Value (2021 & 2025 & 2032)
- 1.6.2 Global AD Cerebrospinal Fluid (CSF) Assay Kit Sales Quantity (2021-2032)
- 1.6.3 Global AD Cerebrospinal Fluid (CSF) Assay Kit Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Roche
- 2.1.1 Roche Details
- 2.1.2 Roche Major Business
- 2.1.3 Roche AD Cerebrospinal Fluid (CSF) Assay Kit Product and Services
- 2.1.4 Roche AD Cerebrospinal Fluid (CSF) Assay Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Roche Recent Developments/Updates
- 2.2 Fujirebio
- 2.2.1 Fujirebio Details
- 2.2.2 Fujirebio Major Business
- 2.2.3 Fujirebio AD Cerebrospinal Fluid (CSF) Assay Kit Product and Services
- 2.2.4 Fujirebio AD Cerebrospinal Fluid (CSF) Assay Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Fujirebio Recent Developments/Updates
- 2.3 Euroimmun (Revvity)
- 2.3.1 Euroimmun (Revvity) Details
- 2.3.2 Euroimmun (Revvity) Major Business
- 2.3.3 Euroimmun (Revvity) AD Cerebrospinal Fluid (CSF) Assay Kit Product and Services
- 2.3.4 Euroimmun (Revvity) AD Cerebrospinal Fluid (CSF) Assay Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Euroimmun (Revvity) Recent Developments/Updates
- 2.4 IBL International
- 2.4.1 IBL International Details
- 2.4.2 IBL International Major Business
- 2.4.3 IBL International AD Cerebrospinal Fluid (CSF) Assay Kit Product and Services
- 2.4.4 IBL International AD Cerebrospinal Fluid (CSF) Assay Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 IBL International Recent Developments/Updates
- 2.5 Quanterix
- 2.5.1 Quanterix Details
- 2.5.2 Quanterix Major Business
- 2.5.3 Quanterix AD Cerebrospinal Fluid (CSF) Assay Kit Product and Services
- 2.5.4 Quanterix AD Cerebrospinal Fluid (CSF) Assay Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Quanterix Recent Developments/Updates
3 Competitive Environment: AD Cerebrospinal Fluid (CSF) Assay Kit by Manufacturer
- 3.1 Global AD Cerebrospinal Fluid (CSF) Assay Kit Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global AD Cerebrospinal Fluid (CSF) Assay Kit Revenue by Manufacturer (2021-2026)
- 3.3 Global AD Cerebrospinal Fluid (CSF) Assay Kit Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of AD Cerebrospinal Fluid (CSF) Assay Kit by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 AD Cerebrospinal Fluid (CSF) Assay Kit Manufacturer Market Share in 2025
- 3.4.3 Top 6 AD Cerebrospinal Fluid (CSF) Assay Kit Manufacturer Market Share in 2025
- 3.5 AD Cerebrospinal Fluid (CSF) Assay Kit Market: Overall Company Footprint Analysis
- 3.5.1 AD Cerebrospinal Fluid (CSF) Assay Kit Market: Region Footprint
- 3.5.2 AD Cerebrospinal Fluid (CSF) Assay Kit Market: Company Product Type Footprint
- 3.5.3 AD Cerebrospinal Fluid (CSF) Assay Kit Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global AD Cerebrospinal Fluid (CSF) Assay Kit Market Size by Region
- 4.1.1 Global AD Cerebrospinal Fluid (CSF) Assay Kit Sales Quantity by Region (2021-2032)
- 4.1.2 Global AD Cerebrospinal Fluid (CSF) Assay Kit Consumption Value by Region (2021-2032)
- 4.1.3 Global AD Cerebrospinal Fluid (CSF) Assay Kit Average Price by Region (2021-2032)
- 4.2 North America AD Cerebrospinal Fluid (CSF) Assay Kit Consumption Value (2021-2032)
- 4.3 Europe AD Cerebrospinal Fluid (CSF) Assay Kit Consumption Value (2021-2032)
- 4.4 Asia-Pacific AD Cerebrospinal Fluid (CSF) Assay Kit Consumption Value (2021-2032)
- 4.5 South America AD Cerebrospinal Fluid (CSF) Assay Kit Consumption Value (2021-2032)
- 4.6 Middle East & Africa AD Cerebrospinal Fluid (CSF) Assay Kit Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global AD Cerebrospinal Fluid (CSF) Assay Kit Sales Quantity by Type (2021-2032)
- 5.2 Global AD Cerebrospinal Fluid (CSF) Assay Kit Consumption Value by Type (2021-2032)
- 5.3 Global AD Cerebrospinal Fluid (CSF) Assay Kit Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global AD Cerebrospinal Fluid (CSF) Assay Kit Sales Quantity by Application (2021-2032)
- 6.2 Global AD Cerebrospinal Fluid (CSF) Assay Kit Consumption Value by Application (2021-2032)
- 6.3 Global AD Cerebrospinal Fluid (CSF) Assay Kit Average Price by Application (2021-2032)
7 North America
- 7.1 North America AD Cerebrospinal Fluid (CSF) Assay Kit Sales Quantity by Type (2021-2032)
- 7.2 North America AD Cerebrospinal Fluid (CSF) Assay Kit Sales Quantity by Application (2021-2032)
- 7.3 North America AD Cerebrospinal Fluid (CSF) Assay Kit Market Size by Country
- 7.3.1 North America AD Cerebrospinal Fluid (CSF) Assay Kit Sales Quantity by Country (2021-2032)
- 7.3.2 North America AD Cerebrospinal Fluid (CSF) Assay Kit Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe AD Cerebrospinal Fluid (CSF) Assay Kit Sales Quantity by Type (2021-2032)
- 8.2 Europe AD Cerebrospinal Fluid (CSF) Assay Kit Sales Quantity by Application (2021-2032)
- 8.3 Europe AD Cerebrospinal Fluid (CSF) Assay Kit Market Size by Country
- 8.3.1 Europe AD Cerebrospinal Fluid (CSF) Assay Kit Sales Quantity by Country (2021-2032)
- 8.3.2 Europe AD Cerebrospinal Fluid (CSF) Assay Kit Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific AD Cerebrospinal Fluid (CSF) Assay Kit Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific AD Cerebrospinal Fluid (CSF) Assay Kit Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific AD Cerebrospinal Fluid (CSF) Assay Kit Market Size by Region
- 9.3.1 Asia-Pacific AD Cerebrospinal Fluid (CSF) Assay Kit Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific AD Cerebrospinal Fluid (CSF) Assay Kit Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America AD Cerebrospinal Fluid (CSF) Assay Kit Sales Quantity by Type (2021-2032)
- 10.2 South America AD Cerebrospinal Fluid (CSF) Assay Kit Sales Quantity by Application (2021-2032)
- 10.3 South America AD Cerebrospinal Fluid (CSF) Assay Kit Market Size by Country
- 10.3.1 South America AD Cerebrospinal Fluid (CSF) Assay Kit Sales Quantity by Country (2021-2032)
- 10.3.2 South America AD Cerebrospinal Fluid (CSF) Assay Kit Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa AD Cerebrospinal Fluid (CSF) Assay Kit Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa AD Cerebrospinal Fluid (CSF) Assay Kit Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa AD Cerebrospinal Fluid (CSF) Assay Kit Market Size by Country
- 11.3.1 Middle East & Africa AD Cerebrospinal Fluid (CSF) Assay Kit Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa AD Cerebrospinal Fluid (CSF) Assay Kit Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 AD Cerebrospinal Fluid (CSF) Assay Kit Market Drivers
- 12.2 AD Cerebrospinal Fluid (CSF) Assay Kit Market Restraints
- 12.3 AD Cerebrospinal Fluid (CSF) Assay Kit Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of AD Cerebrospinal Fluid (CSF) Assay Kit and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of AD Cerebrospinal Fluid (CSF) Assay Kit
- 13.3 AD Cerebrospinal Fluid (CSF) Assay Kit Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 AD Cerebrospinal Fluid (CSF) Assay Kit Typical Distributors
- 14.3 AD Cerebrospinal Fluid (CSF) Assay Kit Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on AD Cerebrospinal Fluid (CSF) Assay Kit. Industry analysis & Market Report on AD Cerebrospinal Fluid (CSF) Assay Kit is a syndicated market report, published as Global AD Cerebrospinal Fluid (CSF) Assay Kit Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of AD Cerebrospinal Fluid (CSF) Assay Kit market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
